Genentech, Inc. et al v. Aizant Drug Research Solutions Pvt. Ltd.
| Genentech, Inc. and InterMune, Inc. |
| Aizant Drug Research Solutions Pvt. Ltd. |
| 1:2019cv00223 |
| February 1, 2019 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 27, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney Ronald M. Daignault and Richard Juang, filed by Aizant Drug Research Solutions Pvt. Ltd.. Signed by Judge Richard G. Andrews on 3/27/2019. (nms)
|
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Ronald M. Daignault and Richard Juang - filed by Aizant Drug Research Solutions Pvt. Ltd.. (Stamoulis, Stamatios) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Aizant Drug Research Solutions Pvt. Ltd.. (Stamoulis, Stamatios) |
| Filing 9 ANSWER to #1 Complaint, Affirmative Defenses, and COUNTERCLAIMS against Genentech, Inc., InterMune, Inc., by Aizant Drug Research Solutions Pvt. Ltd..(Stamoulis, Stamatios) Modified on 3/19/2019 (nms). |
| Pro Hac Vice Attorneys Ryan Hagglund, Warren K. MacRae, and Mark E. Waddell for Genentech, Inc. and InterMune, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00078-RGA et al.(ddp) |
|
SO ORDERED, re #8 STIPULATION TO EXTEND TIME to answer or otherwise respond to the Complaint to Mach 18, 2019 (*Reset Answer Deadlines: Aizant Drug Research Solutions Pvt. Ltd. answer due 3/18/2019). Signed by Judge Richard G. Andrews on 2/21/2019. (nms)
|
| Filing 8 STIPULATION TO EXTEND TIME to answer or otherwise respond to the Complaint to Mach 18, 2019 - filed by Aizant Drug Research Solutions Pvt. Ltd.. (Stamoulis, Stamatios) |
|
SO ORDERED, re (11 in 19-cv-78-RGA, 8 in 19-cv-154-RGA, 7 in 19-cv-202-RGA, 8 in 19-cv-130-RGA, 9 in 19-cv-103-RGA, 9 in 19-cv-110-RGA, 9 in 19-cv-123-RGA, 8 in 19-cv-205-RGA, 8 in 19-cv-219-RGA, 10 in 19-cv-178-RGA, 13 in 19-cv-131-RGA, 7 in 19-cv-223-RGA, 7 in 19-cv-142-RGA, 7 in 19-cv-136-RGA, 11 in 19-cv-104-RGA, 8 in 19-cv-190-RGA, 7 in 19-cv-141-RGA, 8 in 19-cv-177-RGA, 13 in 19-cv-132-RGA, 9 in 1:19-cv-00120-RGA, 8 in 19-cv-111-RGA, 8 in 19-cv-195-RGA, 9 in 19-cv-105-RGA, 9 in 1:19-cv-00109-RGA, 7 in 19-cv-203-RGA, 10 in 19-cv-164-RGA) MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP filed by Genentech, Inc., InterMune, Inc.. Signed by Judge Richard G. Andrews on 2/12/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms)
|
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) |
| Filing 6 AFFIDAVIT of Service for Complaint and related papers served on Aizant Drug Research Solutions Pvt. Ltd. on February 5, 2019, filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:19-cv-00177-RGA, 1:19-cv-00178-RGA, 1:19-cv-00190-RGA, 1:19-cv-00195-RGA, 1:19-cv-00202-RGA, 1:19-cv-00203-RGA, 1:19-cv-00205-RGA, 1:19-cv-00219-RGA, 1:19-cv-00223-RGA (rjb) |
| Summons Issued with Magistrate Consent Notice attached as to Aizant Drug Research Solutions Pvt. Ltd. on 2/4/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (rwc) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Genentech, Inc. for InterMune, Inc.; Corporate Parent Roche Holding Ltd., Corporate Parent Novartis Ltd., Corporate Parent Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc., InterMune, Inc. (rwc) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,566,729 B1 ;7,635,707 B1 ;7,767,700 B2 ;7,816,383 B1 ;7,910,610 B1. (rwc) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/22/18. Date of Expiration of Patent: 9/22/26 through 8/30/33.Thirty Month Stay Deadline: 8/15/2022. (rwc) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Aizant Drug Research Solutions Pvt. Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2560144.) - filed by InterMune, Inc., Genentech, Inc. (Attachments: #1 Exhibit 1-15, #2 Civil Cover Sheet)(rwc) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
